A
Applied StemCell
Biotech & Life Sciences · Milpitas, United States · Founded 2008
Advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry MoreLess
Applied StemCell, Inc. operates in the biotechnology sector, specializing in CRISPR-based genome editing and stem cell services. The company provides a range of services including the creation of genetically modified cell lines, animal models, and comprehensive preclinical studies. Applied StemCell serves clients in the pharmaceutical, biotechnology, and academic research sectors, focusing on cancer and stem cell research. The company generates revenue through custom service contracts, product sales, and licensing agreements. Their business model is centered around offering high-quality, tailored solutions to accelerate basic research and drug discovery. Key offerings include iPSC differentiation, antibody discovery, and neurotoxicity screening. Applied StemCell's market is global, with a strong emphasis on innovation and precision in genetic engineering.
Keywords: CRISPR, genome editing, stem cells, cancer research, neuroscience, iPSC, antibody discovery, preclinical studies, animal models, biotechnology.
Company overview
Applied StemCell company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2008
- Headquarters
- Milpitas, United States
- Employees
- 49
- Open positions
- 1
- Dealroom signal
- 66.2
Valuation & funding
Applied StemCell funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| BUYOUT✓Exit | Oct 2023 | $0 | — | QHP Capital | ↗ |
| SERIES D✓Equity / VC | Jun 2016 | $19M | $76M | Ping An Ventures · Viventures · Hermed Capital | — |
| SERIES C✓Equity / VC | Mar 2013 | $2.6M | $10M | Undisclosed | — |
| SERIES B✓Equity / VC | Mar 2010 | $1.9M | $7.6M | Undisclosed | — |
| SERIES A✓Equity / VC | Jun 2008 | $0 | — | Undisclosed | — |
| SPINOUT✓Other financing | Jan 2008 | Stanford University | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 51 |
| 2025 | 53 |
| 2024 | 53 |
| 2023 | 35 |
| 2022 | 44 |
| 2021 | 44 |
| 2020 | 48 |
Growth signals
Applied StemCell website traffic
Latest recorded traffic for Applied StemCell is 6.4K monthly website visits, down 83.2% over the last three months. Applied StemCell's team declined 7.5% over the past year.
Hiring
Open positions at Applied StemCell
Current openings linked to this company in Dealroom.
Comparisons
Applied StemCell compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Applied StemCell's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Applied StemCell has talent and traffic
team presence
In the news
Latest news about Applied StemCell
Recent press, funding announcements, and product moves mentioning Applied StemCell — open to read from the original sources.
Market sentiment
What the market is saying about Applied StemCell
An AI-synthesized read of the highest-engagement posts about Applied StemCell on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Applied StemCell’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.